1-15 of 916
Not Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Conversations in CV Risk AssessmentNot Just for Diabetes: Broadening uACR Screening to CV Risk Populations
Unseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
Conversations in CV Risk AssessmentUnseen Disease: The Diagnostic Barriers to CKD and CV Risk Prevention
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's RoundtableAI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's RoundtableMulti-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstractsTargeting the Hippo Pathway in Pulmonary Arterial Hypertension
Hypertension in Women: Cardiovascular Risk Across the Lifespan
Heart MattersHypertension in Women: Cardiovascular Risk Across the Lifespan
- advertisement
Predicting the Heart’s Future: Albuminuria as a CV Warning Sign
Conversations in CV Risk AssessmentPredicting the Heart’s Future: Albuminuria as a CV Warning Sign
Heart Failure and Albuminuria: Connecting the Dots
Conversations in CV Risk AssessmentHeart Failure and Albuminuria: Connecting the Dots
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart MattersRecognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstractsExploring Deeper Silencing in Transthyretin Amyloidosis
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstractsHow Symptoms Shape Caregiver Burden in ATTR-CM
- advertisement
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies



















































